Associate Professor, Neurology, Washington University School of Medicine
Neurology
Dr. Randall J. Bateman, MD
|
|
Give Review
Randall J. Bateman is an expert in the field of Neurology. He researched medicine at Case Western Reserve University School of Medicine. He has 2 awards "Elected Member" and "CMS Meaningful Use Stage 1 Certification". Randall Bateman is also a published doctor. He has 44 publication published. The most recent publication is: Localization of O-glycosylation sites of MUC1 tandem repeats by QTOF ESI mass spectrometry. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Early behavioural changes in familial Alzheimer's Disease in the Dominantly Inherited Alzheimer Network.
- Factors associated with the onset and persistence of post-lumbar puncture Headache.
- Decreased Platelet APP Isoform Ratios in Autosomal Dominant Alzheimer's Disease: Baseline Data from a DIAN Cohort Subset.
- Partial volume correction in quantitative amyloid imaging.
- Analysis of a compartmental model of amyloid beta production, irreversible loss and exchange in humans.
- Reply to comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice".
- Functional connectivity in autosomal dominant and late-onset Alzheimer Disease.
- Amyloid-β efflux from the CNS into the plasma.
- Advancing research diagnostic criteria for Alzheimer's Disease: the IWG-2 criteria.
- Symptom onset in autosomal dominant Alzheimer Disease: A systematic review and meta-analysis.
- Amyloid-β diurnal pattern: possible role of sleep in Alzheimer's Disease pathogenesis.
- An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice.
- Continuous 24-hour leptin, proopiomelanocortin, and amino Acid measurements in human cerebrospinal fluid: correlations with plasma leptin, soluble leptin receptor, and...
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease.
- Regional variability of imaging biomarkers in autosomal dominant Alzheimer's Disease.
- Dominantly Inherited Alzheimer Network: facilitating research and clinical trials.
- Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial.
- The pattern of atrophy in familial Alzheimer Disease: Volumetric MRI results from the DIAN study.
- Impaired default network functional connectivity in autosomal dominant Alzheimer Disease.
- Amyloid-beta Isoform Metabolism Quantitation by Stable Isotope Labeled Kinetics.
- Amyloid-beta oligomerization in Alzheimer Dementia versus high-pathology controls.
- Exposure of the lysine in the gamma chain dodecapeptide of human fibrinogen is not enhanced by adsorption to poly(ethylene terephthalate) as measured by biotinylation ...
- Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system.
- Human apoE isoforms differentially regulate Brain amyloid-β peptide clearance.
- Autosomal-dominant Alzheimer's Disease: a review and proposal for the prevention of Alzheimer's Disease.
- Reply to: Fractional synthesis and clearance rates for amyloid ?.
- Decreased clearance of CNS beta-amyloid in Alzheimer's Disease.
- Acute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments wi...
- Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry.
- Amyloid-beta dynamics are regulated by orexin and the Sleep-wake cycle.
- A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.
- Stable isotope labeling tandem mass spectrometry (SILT): integration with peptide identification and extension to data-dependent scans.
- Measuring target effect of proposed Disease-modifying therapies in Alzheimer's Disease.
- Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates.
- Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.
- Testing a test for Alzheimer Disease.
- Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.
- Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.
- Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
- Localization of O-glycosylation sites of MUC1 tandem repeats by QTOF ESI mass spectrometry.
- Neurofilament light chain levels in ventricular cerebrospinal fluid after acute Aneurysmal subarachnoid haemorrhage.
- Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism.
- Alternative processing of ?-secretase substrates in common forms of mild cognitive impairment and alzheimer's Disease: Evidence for ?-secretase dysfunction.
Schools
Case Western Reserve University School of Medicine
Barnes Hospital Bjc
Wash University School Med
Wash University Barnes Hospital
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Brain Aneurysm
- Cerebral Artery Thrombosis
- Convulsions
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Elected Member
- CMS Meaningful Use Stage 1 Certification
Education
-
Washington University - Barnes-Jewish Hospital -
Case Western Reserve University School of Medicine
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1649296872 | |
| NPPES Provider LastName | BATEMAN | |
| NPPES Provider FirstName | RANDALL | |
| NPPES Provider ZIPCode | 631082215 | |
| NPPES Provider State | MO | |
| Specialty Description | Neurology | |
| Total Claim Count | 124.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649296872 |
| Last Name Of The Provider | BATEMAN |
| First Name Of The Provider | RANDALL |
| View All |
Similar Doctors
|
|
Andrew Findlay
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel S. Perlmutter, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kevin Ess, DO |
|
|
Dr. Norman E. Trevathan III, MD |
|
|
Dr. K Philip Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott A. Norris, MD |
|
|
Dr. Gabriel A. De Erausquin, MD |